CIK 0001815442 · Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812992166
- Phone
- 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-08 | Gollob Jared Chief Medical Officer | Sale 10b5-1 | −18,357 | $88.02 | $1.6M | 127,183 |
| 2025-12-08 | Gollob Jared Chief Medical Officer | Sale 10b5-1 | −3,929 | $89.43 | $351K | 123,254 |
| 2025-12-08 | Gollob Jared Chief Medical Officer | Sale 10b5-1 | −8,562 | $90.12 | $772K | 114,692 |
| 2025-12-08 | Gollob Jared Chief Medical Officer | Sale 10b5-1 | −3,300 | $91.46 | $302K | 111,392 |
| 2025-12-08 | Gollob Jared Chief Medical Officer | Sale 10b5-1 | −1,400 | $92.19 | $129K | 109,992 |
| 2025-12-08 | Gollob Jared Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −49,307 | 34,083 | ||
| 2025-10-29 | Mainolfi Nello Chief Executive Officer | Option exercise 10b5-1 | +30,000 | $2.08 | $62K | 690,482 |
| 2025-10-29 | Mainolfi Nello Chief Executive Officer | Sale 10b5-1 | −1,862 | $59.72 | $111K | 688,620 |
| 2025-10-29 | Mainolfi Nello Chief Executive Officer | Sale 10b5-1 | −24,511 | $61.02 | $1.5M | 664,109 |
| 2025-10-29 | Mainolfi Nello Chief Executive Officer | Sale 10b5-1 | −3,627 | $61.46 | $223K | 660,482 |
| 2025-10-29 | Mainolfi Nello Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 405,559 | ||
| 2025-10-15 | Gollob Jared Chief Medical Officer | Option exercise 10b5-1 | +28,999 | $1.31 | $38K | 147,358 |
| 2025-10-15 | Gollob Jared Chief Medical Officer | Option exercise 10b5-1 | +22,210 | $2.08 | $46K | 169,568 |
| 2025-10-15 | Gollob Jared Chief Medical Officer | Sale 10b5-1 | −29,264 | $60.37 | $1.8M | 140,304 |
| 2025-10-15 | Gollob Jared Chief Medical Officer | Sale 10b5-1 | −8,963 | $61.49 | $551K | 131,341 |
| 2025-10-15 | Gollob Jared Chief Medical Officer | Sale 10b5-1 | −14,896 | $62.72 | $934K | 116,445 |
| 2025-10-15 | Gollob Jared Chief Medical Officer | Sale 10b5-1 | −6,453 | $63.09 | $407K | 109,992 |
| 2025-10-15 | Gollob Jared Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −28,999 | 0 | ||
| 2025-10-15 | Gollob Jared Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −22,210 | 0 | ||
| 2025-10-13 | Gollob Jared Chief Medical Officer | Option exercise 10b5-1 | +800 | $1.31 | $1K | 120,800 |
Page 20 of 25 · 493 trades